Latest Asx Listing Rules News

Group 6 Metals disclosed breaches of ASX Listing Rule 10.1 due to related party transactions made without required shareholder approval during a period of negative equity. The company will seek retrospective approval at a July meeting and has since returned to positive equity.

Bio-Gene Technology has expanded its capital raise to $2.775 million through a share placement priced at 2.5 cents, attaching options exercisable at 3.5 cents pending shareholder approval.

Yugo Metals has secured a $5 million oversubscribed placement to ramp up drilling across its gold, nickel-cobalt, and base metals projects in the Balkans, positioning the company for significant exploration milestones over the next 18 months.

a2 Milk confirms no undisclosed information behind recent share price moves, attributing volatility to a CLSA downgrade citing supply delays and previously disclosed risks.

VanEck Investments Limited has issued a comprehensive Replacement Product Disclosure Statement for eight of its Australian ETFs, detailing investment strategies, fees, risks, and operational protocols under ASX AQUA Rules.

ARC Funds Limited has secured $600,000 through a share placement priced at a 33% premium to its last traded price, aiming to strengthen its working capital and support growth initiatives.

Evion Group has increased the size of its second tranche placement, lifting total capital raised to A$7.24 million through the issue of over 241 million shares at 3 cents each. The second tranche awaits shareholder approval at a July meeting, including director participation and free attaching options.

IDP Education (ASX:IEL) has responded to an ASX price query following a sharp share price fall and increased trading volume, attributing the movement to a late analyst downgrade and confirming compliance with continuous disclosure rules.

AnteoTech has locked in an underwriting deal to guarantee up to $7.5 million from the exercise of listed options, potentially raising as much as $10 million before costs.

Canterbury Resources reaffirms its commitment to Central Queensland copper exploration by clarifying details of its acquisition of the Monto Project, highlighting the John Hill deposit’s significant inferred resource and plans for deep drilling in 2026.

Racura Oncology has locked in an underwriting agreement covering nearly 1.84 million expiring options, ensuring up to $2.3 million in fresh capital to back its cancer drug development programs.

QEM Limited has pushed back the deadline to complete due diligence on its planned acquisition of two U.S. critical minerals projects, citing legal and environmental concerns that require further investigation.